Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Leases (2022 - 2025)

Biodesix (BDSX) has disclosed Current Leases for 4 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 89.71% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Dec 2025, up 89.71%, and an annual FY2025 reading of $1.4 million, up 89.71% over the prior year.
  • Current Leases was $1.4 million for Q4 2025 at Biodesix, down from $1.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.8 million in Q1 2023 and bottomed at $252000.0 in Q4 2023.
  • Average Current Leases over 4 years is $1.1 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Current Leases plummeted 84.56% in 2024, then surged 310.67% in 2025.
  • Year by year, Current Leases stood at $1.5 million in 2022, then plummeted by 83.67% to $252000.0 in 2023, then soared by 185.32% to $719000.0 in 2024, then skyrocketed by 89.71% to $1.4 million in 2025.
  • Business Quant data shows Current Leases for BDSX at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.2 million in Q2 2025.